Search
for
Sort by
Research 61–90 of 1000+
- Is dehydroepiandrosterone a hormone?
- Androgens and androgen receptor action in skin and hair follicles
- Hormonal treatment of acne vulgaris: an update
- Clinical review 74: Dermatological manifestations of endocrine disorders.
- Transcriptomics analysis reveals molecular alterations underpinning spaceflight dermatology
- Dermatological medications and local therapeutics
- Pubertal Acne
- Dermatophytosis in companion animals: A review
- Prolactin: A Mammalian Stress Hormone and Its Role in Cutaneous Pathophysiology
- The myeloid mineralocorticoid receptor regulates dermal angiogenesis and inflammation in glucocorticoid‐induced impaired wound healing
- Decreased GATA3 levels cause changed mouse cutaneous innate lymphoid cell fate, facilitating hair follicle recycling
- Epidermal PPARγ Is a Key Homeostatic Regulator of Cutaneous Inflammation and Barrier Function in Mouse Skin
- Cutaneous manifestations of endocrine diseases in children
- Cutaneous Retinoic Acid Levels Determine Hair Follicle Development and Downgrowth
- Palatogenesis and cutaneous repair: A two‐headed coin
- An overview of animal models induced by glucocorticoids
- The importance of the neuro‐immuno‐cutaneous system on human skin equivalent design
- Human Follicular Papilla Cells Carry Out Nonadipose Tissue Production of Leptin
- Topical use of systemic drugs in dermatology: A comprehensive review
- Three cases of immune‐mediated adnexal skin disease treated with cyclosporin
- Lithium therapy associated with hidradenitis suppurativa: Case report and a review of the dermatologic side effects of lithium
- Proopiomelanocortin (POMC) and Psychodermatology
- Telitacicept for systemic lupus erythematosus with post‑surgical papillary thyroid carcinoma: A case report
- Cholesterol homeostasis in hair follicle keratinocytes is disrupted by impaired ABCA5 activity
- The significance of CYP11A1 expression in skin physiology and pathology
- Hormonal Therapies in Cosmetic Dermatology: Mechanisms, Clinical Applications, and Future Perspectives
- Pharmacotherapy for Keloids and Hypertrophic Scars
- Non‐biologic immunosuppressive drugs for inflammatory and autoimmune skin diseases
- Localization, Age- and Site-Dependent Expression, and Regulation of 11β-Hydroxysteroid Dehydrogenase Type 1 in Skin
- Microneedles as transdermal drug delivery system for enhancing skin disease treatment